Pregabalin Caps 200mg 90s Count
Pregabalin Capsule
Product Images NDC 68788-7527
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 68788-7527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pregabalin Fig01)
Figure 2 (Pregabalin Fig02)
Figure 3 (Pregabalin Fig03)
Figure 4 (Pregabalin Fig04)
Figure 5 (Pregabalin Fig05)
Figure 6 (Pregabalin Fig06)
The text seems to be a table or a graph with different doses of medication (placebo, 50mg/day, 150mg/day, 300mg/day, and 600mg/day) for two studies (E1 and E3) being compared in terms of their statistical significance. Unfortunately, it does not provide further information as to the nature of the studies, or the specific outcome being measured.*
Figure 7 (Pregabalin Fig07)
Figure 9 (Pregabalin Fig08)
The text represents a graph showing the percentage of patients who experienced an improvement in pain from baseline when taking different doses of Pregabalin (300mg and 450mg) compared to a placebo. The X-axis shows the improvement in pain from baseline, while the Y-axis displays the different doses of Pregabalin and the placebo. It is not possible to analyze the graph without having access to the visual representation.*
Figure 10 (Pregabalin Fig09)
The text appears to be a table showing estimated percentage of subjects without LTR for a drug called "Progabain" and a placebo over a period of up to 180 days. The percentages range from 0% to 100% at varying intervals.*
Figure 11 (Pregabalin Fig10)
Figure 12 (Pregabalin Fig11)
Percent of subjects improved data is provided in the text. It indicates the percent of improvement of the subjects from Bassine to Week 16. It also includes some garbled text.*
Cockcroft And Gault Equation (Pregabalin Formula)
This appears to be a medical formula for calculating the CLCT (creatinine clearance) of a patient. The formula uses the patient's age in years and weight in kilograms, along with their serum creatinine level in milligrams per deciliter. The variable "mmmmmmmmm" is not readable, but it is likely a placeholder for a constant value that would be used in the calculation. For female patients, the result is multiplied by 0.85.*
Chemical Structure (Pregabalin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
